基于PTV富集血液炎症生物标志物的脑转移瘤立体定向放射外科治疗后放射性坏死风险预测新模型
本研究回顾性分析47例接受单次或分次立体定向放射治疗的脑转移瘤患者血浆样本,采用Olink蛋白组学检测92种炎症相关蛋白,结合PTV建立放射性坏死预测模型。组织分析证实放射性坏死灶呈促炎微环境。
要点
- PTV、MUC-16和CXCL11是脑转移瘤SRS后放射性坏死的独立预测因子。
- 联合PTV与MUC-16、CXCL11的坏死预测指数与RN风险显著相关,AUC为0.808。
- 组织分析显示RN灶较肿瘤复发呈促炎免疫微环境。
核心结论
- PTV联合CXCL11和MUC-16可能预测脑转移瘤SRS后症状性放射性坏死的发生,需进一步验证。
研究设计与样本
- 回顾性研究,纳入47例接受单次或3-6次分次立体定向放射治疗的脑转移瘤患者血浆样本(21例RN,26例无RN)。
- 采用Olink 96靶向免疫肿瘤panel分析92种相关人蛋白,统计方法包括ROC曲线和多因素Cox比例风险回归。
- 对可获得的RN组织样本进行多重免疫表型分析以评估免疫浸润。
主要发现
- Cox回归分析确定PTV和炎症相关血液生物标志物MUC-16、CXCL11为RN的独立预测因子。
- ROC分析显示坏死预测指数有效区分RN患者,AUC为0.808。
- 探索性独立分析发现其他促炎血液标志物(CD8a和IL-8)基线水平也与RN相关。
- 组织分析证实RN较肿瘤复发呈促炎微环境。
关键数值与推荐
- 坏死预测指数区分RN的AUC为0.808。
临床怎么用
- 在SRS前可考虑检测血浆MUC-16、CXCL11并结合PTV计算坏死预测指数以评估RN风险。
- 该模型为假设生成性结果,尚不能直接用于临床决策,需外部验证。
局限性
- 本研究为假设生成性回顾性研究,样本量有限(47例),需进一步验证。
- 原文未报告多中心外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation necrosis (RN) is an adverse event following stereotactic radiosurgery (SRS) for brain metastases (BMs). The planning target volume (PTV) size is a potential yet suboptimal predictor of RN, unlike V12, which remains independent of the number of fractions delivered. Prior authors demonstrated that radiation-induced brain injury can be traced in peripheral blood. This study aimed to identify predictive biomarkers of symptomatic RN at the time of SRS to develop a risk prediction model based on inflammatory proteomic plasma markers and the PTV as dosimetric surrogate. METHODS AND MATERIALS: A retrospective study design was conducted using plasma samples from patients with BMs treated with SRS (single fraction) or fractionated stereotactic radiation therapy (3-6 fractions). The Olink 96 Target Immuno-Oncology Panel was used to analyze 92 related human proteins using oligonucleotide-bound antibodies and real-time polymerase chain reaction. Statistical analyses included receiver operating characteristic curves and multivariable Cox proportional hazards regression to evaluate clinical parameters, PTV, and blood biomarkers to predict RN risk. Multiplex immunophenotyping was performed on available RN tissue samples to assess immune infiltration. RESULTS: A total of 47 patients with BMs were analyzed (21 cases with RN and 26 without). Cox regression analysis identified PTV and the inflammation-related blood biomarkers MUC-16 and CXCL11 as independent predictors of RN. A high Necrosis Predictive Index combining PTV with MUC-16 and CXCL11 was significantly associated with a higher risk (hazard ratio = 2.543 [1.615-4.005]; P < .0001) of RN development. Receiver operating characteristic analysis demonstrated that the Necrosis Predictive Index effectively distinguished patients with RN, achieving an area under the curve of 0.808. An exploratory independent analysis found that baseline levels of other proinflammatory blood biomarkers (ie, CD8a and IL-8) were also associated with RN. Tissue analysis confirmed a proinflammatory microenvironment in RN compared with tumor recurrence. CONCLUSIONS: This hypothesis-generating study suggests the combination of PTV, CXCL11, and MUC-16 may predict the development of RN, warranting further validation.
引用
- Jablonska PA, Serrano D, Galán N, et al. A New Predictive Model for Radiation Necrosis Risk Based on PTV-Enriched Blood Inflammatory Biomarkers in Patients With Brain Metastases Treated With Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys. 2026. PMID: 41831794. doi:10.1016/j.ijrobp.2026.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。